How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,141 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Headaches in over 12s: diagnosis and management

Seek specialist advice if prophylactic treatment for migraine is needed during pregnancy. [2012] [2012] Cluster headache Cluster headache Acute tr Acute treatment eatment 1.3.28 Discuss the need for neuroimaging for people with a first bout of cluster headache with a GP with a special interest in headache or a neurologist. [2012] [2012] 1.3.29 Offer oxygen and/or a subcutaneous [17] or nasal triptan [18] for the acute treatment of cluster headache. [2012] [2012] 1.3.30 When using oxygen (...) before starting verapamil, including advice on electrocardiogram monitoring. [2012] [2012] 1.3.34 Seek specialist advice for cluster headache that does not respond to verapamil [19] . [2012] [2012] 1.3.35 Seek specialist advice if treatment for cluster headache is needed during pregnancy. [2012] [2012] Medication o Medication ov veruse headache eruse headache 1.3.36 Explain to people with medication overuse headache that it is treated by withdrawing overused medication. [2012] [2012] 1.3.37 Advise

2012 National Institute for Health and Clinical Excellence - Clinical Guidelines

22. Treating Opioid Use Disorder During Pregnancy: Guideline Supplement

Treating Opioid Use Disorder During Pregnancy: Guideline Supplement 1 Guideline Supplement Treatment of Opioid Use Disorder During2 THIS IS A BLANK PAGE3 A Guideline for the Clinical Management of Opioid Use Disorder—Pregnancy Supplement The BC Centre on Substance Use (BCCSU) is a provincially networked platform mandated to develop, imple- ment, and evaluate evidence-based approaches to substance use and addiction. The BCCSU’s focus is on three strategic areas including research and evaluation (...) Health and Addictions, & Perinatal Services BC. A Guideline for the Clinical Management of Opioid Use Disorder—Pregnancy Supplement. Published June 1, 2018. Available at: http://www.bccsu.ca/care-guid- ance-publications/4 AUTHOr S AND CONTr IBUTOr S Guideline Development Committee Ronald Abrahams (Committee Co-chair), MD, CCFP , FCFP , M.S.C.; Clinical Professor, Dept. Family Practice, UBC; Medical Director, Perinatal Addictions, BCWH Andrea Ryan (Committee Co-chair), MD, CCFP , Dip. ISAM; Clinical

2018 British Columbia Perinatal Health Program

23. Management of Cardiovascular Diseases during Pregnancy

Management of Cardiovascular Diseases during Pregnancy We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article navigation 07 September 2018 Article Contents Article Navigation 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy Vera Regitz-Zagrosek Chairperson Corresponding authors. Vera Regitz-Zagrosek, Charité Universitaetsmedizin Berlin, Institute for Gender in Medicine, CCR, DZHK, partner site Berlin, Hessische Str 3-4, 10115 Berlin, Germany, Tel: +49 30 450 525 288, Fax: +49 30 450 7 525 288, E-mail: . Search for other works by this author

Full Text available with Trip Pro

2018 European Society of Cardiology

24. Syphilis in pregnancy

Syphilis in pregnancy Maternity and Neonatal C linical G uideline Queensland Health Syphilis in pregnancy Queensland Clinical Guideline: Syphilis in pregnancy Refer to online version, destroy printed copies after use Page 2 of 31 Document title: Syphilis in pregnancy Publication date: December 2018 Document number: MN18.44-V1-R23 Document supplement: The document supplement is integral to and should be read in conjunction with this guideline. Amendments: Full version history is supplied (...) Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Syphilis in pregnancy Refer to online version, destroy printed copies after use Page 3 of 31 Flow Chart: Antenatal care IM: intramuscular injection, MSM: Men who have sex with men, PCR: Polymerase Chain Reaction QSSS: Queensland Syphilis Surveillance Service, STI: sexually transmitted infection, 4 weeks before birth · Indicated following risk assessment

2019 Queensland Health

25. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine - American Journal of Obstetrics & Gynecology Email/Username: Password: Remember me Search Terms Search within Search (...) Share this page: Access provided by Volume 221, Issue 1, Pages B5–B28 Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine The workshop was convened at the 38th Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine in Dallas, TX, January 29–February 2, 2018. x Jeffrey

2019 Society for Maternal-Fetal Medicine

26. UK guidelines on the management of iron deficiency in pregnancy

is associated with increased risk of perinatal morbidity and mortality, and has important potential implications for the future neuro‐development of the infant (2B). Diagnosis Clinical symptoms and signs The clinical symptoms of iron deficiency anaemia in pregnancy are non‐specific and cannot be relied on for diagnostic purposes. Fatigue is the most common symptom but women may also present with pallor, weakness, headache, palpitations, dizziness, dyspnoea, irritability and restless legs. Pica, a craving (...) UK guidelines on the management of iron deficiency in pregnancy UK guidelines on the management of iron deficiency in pregnancy - Pavord - - British Journal of Haematology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Guideline Free Access UK guidelines on the management of iron deficiency in pregnancy Department of Haematology, Oxford University Hospitals, Oxford, UK Women's Health Research

2019 British Committee for Standards in Haematology

27. New measures to avoid valproate exposure in pregnancy endorsed

and with patients, including women and their children who have been affected by valproate use during pregnancy, through written submissions, expert meetings, meetings with stakeholders (including healthcare professionals, patients organisations, patients and their families), and via a . More about the medicine Valproate medicines are used to treat epilepsy and bipolar disorder. In some EU Member States they are also authorised to prevent migraine headaches. The active ingredient in these medicines may (...) New measures to avoid valproate exposure in pregnancy endorsed New measures to avoid valproate exposure in pregnancy endorsed | European Medicines Agency Search Search Menu New measures to avoid valproate exposure in pregnancy endorsed Press release 23/03/2018 Member State representatives agree new restrictions and pregnancy prevention programme The 1 has endorsed new measures to avoid exposure of babies to valproate medicines in the womb, because exposed babies are at high risk

2018 European Medicines Agency - EPARs

28. Migraine and Other Headache Disorders: ACOG Clinical Updates In Women's Health Care Primary and Preventive Care Review Summary Volume XVIII, Number 4. (PubMed)

Migraine and Other Headache Disorders: ACOG Clinical Updates In Women's Health Care Primary and Preventive Care Review Summary Volume XVIII, Number 4. Migraine is a common headache disorder for which women are likely to seek care. This primary headache disorder, which often may be debilitating, has a higher prevalence in women than in men that is likely related to times of hormonal changes throughout the reproductive life cycle, such as menarche, pregnancy, postpartum period, lactation (...) , perimenopause, and menopause, as well as to external hormonal changes associated with the use of oral contraceptives and hormone therapy. The obstetrician-gynecologist is well positioned to recognize and treat migraine and to recognize a potential relationship between estrogen fluctuation and migraine exacerbation. Migraine frequency is likely to decrease during pregnancy, but migraine often recurs during breastfeeding. Because headache does occur during these reproductive events, a careful evaluation

2019 Obstetrics and Gynecology

29. Pregnancy, Birth, Neonatal, and Postnatal Neurological Outcomes After Pregnancy With Migraine. (PubMed)

seizures (aRR: 1.27 [95% CI: 1.03-1.57), but not of death (aRR: 0.67 [95% CI: 0.43-1.04]) and cerebral palsy (aRR: 1.00 [95% CI: 0.51-1.94]).Women with migraine and their offspring have greater risks of several adverse pregnancy outcomes than women without migraine.© 2019 American Headache Society. (...) Pregnancy, Birth, Neonatal, and Postnatal Neurological Outcomes After Pregnancy With Migraine. Prevalence of migraine is high during the reproductive age. Although migraine often improves during pregnancy, the risk of adverse pregnancy, birth, neonatal, and neurological outcomes in mother and offspring remains poorly understood.To investigate the associations between maternal migraine and risks of adverse pregnancy outcomes in the mother, and birth, neonatal and postnatal outcomes

2019 Headache

30. CRACKCast E178 – Co-Morbird Medical Emergencies During Pregnancy

is it managed? Autonomic dysreflexia is the most serious complication of SCI and occurs in up to 85% of women w ith high lesions (above T5-T6) ; it occurs with increased frequency during pregnancy. Autonomic dysreflexia is manifested as severe paroxysmal hypertension, headache, tachycardia, diaphoresis, piloerection, mydriasis, and nasal congestion. It is often precipitated by afferent stimuli from the hollow viscus such as the bladder, bowel, or uterus. Symptoms of autonomic dysreflexia often occur (...) CRACKCast E178 – Co-Morbird Medical Emergencies During Pregnancy CRACKCast E178 - Co-Morbird Medical Emergencies During Pregnancy - CanadiEM CRACKCast E178 – Co-Morbird Medical Emergencies During Pregnancy In by Chris Lipp May 17, 2018 This episode of CRACKCast covers Rosen’s Chapter 178, Co-Morbid Medical Emergencies during Pregnancy. This chapter covers many complicated issues that arise during the care of pregnant patients already suffering from concomitant medical illness, and how to manage

2018 CandiEM

31. CRACKCast E177 – Acute Complications of Pregnancy

blood vessels are present in the membranes covering the internal cervical os. The membranous vessels may be associated with a velamentous umbilical cord (type 1 vasa previa) or they may connect the lobes of a bilobed placenta or the placenta and a succenturiate lobe (type 2 vasa previa). Aberrant blood vessels within 2 cm of the internal os have similar implications to those actually covering the internal os. -Uptodate 2018 5) Which life threatening causes of headache have altered risk in pregnancy (...) ) Serum creatinine >97.2 micromol/L or doubling of the creatinine concentration in the absence of other renal disease Liver transaminases at least twice the upper limit of the normal concentrations Pulmonary edema Cerebral or visual symptoms (eg, new-onset and persistent headaches not responding to usual doses of analgesics* ; blurred vision, flashing lights or sparks, scotomata) 6) Why are pregnant patients at increased risk of VTE? They have the trifecta of virchow! Pregnancy is a hypercoagulable

2018 CandiEM

32. Guideline for primary care management of headache in adults

headache) Jaw symptoms; abnormal jaw examination findings (consider temporomandibular joint disorder) Based on the Scottish Intercollegiate Guidelines Network guideline 29 and expert opinion of the Guideline Development Group. Section 2: migraine A comprehensive approach to migraine management is summarized in . Section 2 of the guideline contains recommendations for lifestyle management, acute treatment, prophylaxis, menstrual migraine, and migraine treatment during pregnancy. The full guideline (...) Intercollegiate Guidelines Network guidelines. 29 Section 3: tension-type headache This section contains recommendations on lifestyle, acute and prophylactic drug therapy, and management of tension-type headache during pregnancy. Recommended medications are outlined in . Section 4: medication-overuse headache Migraine sufferers are particularly prone to developing medication-overuse headache. Recommendations for diagnosis and management of medication-overuse headache are shown in and . Box 8. Diagnosis

2015 Institute of Health Economics

33. Aspirin reduces a woman’s chance of developing pre-eclampsia in pregnancy

one side effect, the most common of which was a headache or dizziness followed by nausea and vomiting. There was also no difference in the rate of serious side effects, which occurred in 1.6% of the aspirin group and 3.2% of the placebo group. What does current guidance say on this issue? 2011 NICE guidelines on hypertension in pregnancy recommend that women at high risk of pre-eclampsia take 75mg of aspirin daily from 12 weeks until the birth of the baby. High-risk factors are high blood pressure (...) for gestational age, preterm delivery (without pre-eclampsia), or pre-eclampsia at term (≥37 weeks). A quarter of women in both groups reported at least one side effect, the most common of which was a headache or dizziness followed by nausea and vomiting. There was also no difference in the rate of serious side effects, which occurred in 1.6% of the aspirin group and 3.2% of the placebo group. What does current guidance say on this issue? 2011 NICE guidelines on hypertension in pregnancy recommend that women

2019 NIHR Dissemination Centre

34. Allergic rhinitis during pregnancy: opt for the lowest risk

, including in women who are or could be pregnant (local irritations, headaches in particular). It is the topical treatment of choice for mild allergic rhinitis in pregnant women. Nasal antihistamines, especially preservative-free azelastine, have not been linked to any particular risk during pregnancy. Oral non-sedating and non-antimuscarinic antihistamines are an alternative to topical treatments when the allergic rhinitis is troublesome: cetirizine is an acceptable option throughout pregnancy (...) Allergic rhinitis during pregnancy: opt for the lowest risk Prescrire IN ENGLISH - Spotlight ''Allergic rhinitis during pregnancy: opt for the lowest risk'', 1 April 2016 {1} {1} {1} | | > > > Allergic rhinitis during pregnancy: opt for the lowest risk Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Allergic rhinitis during pregnancy: opt

2016 Prescrire

35. The Role of Headache in the Classification and Management of Hypertensive Disorders in Pregnancy. (PubMed)

The Role of Headache in the Classification and Management of Hypertensive Disorders in Pregnancy. Hypertensive disorders of pregnancy remain among the leading causes of maternal morbidity and mortality. The onset of headaches in patients with hypertensive disorders of pregnancy has been considered as a premonitory symptom for eclampsia and other adverse maternal outcomes. Headaches are very common symptoms during pregnancy and the postpartum period with a reported incidence of 39%; however (...) , headache is absent in 30-50% of women before the onset of eclampsia and is a poor predictor of eclampsia and adverse maternal outcomes. If included in the definition of cerebral or visual disturbances, headache may be considered a symptom of preeclampsia, a diagnostic feature of preeclampsia with severe features, a premonitory symptom of eclampsia, and an indication for delivery. Inclusion of this nonspecific symptom in the diagnosis and management of hypertensive disorders of pregnancy in the absence

2015 Obstetrics and Gynecology

36. Headache in Pregnancy: An Approach to Emergency Department Evaluation and Management (PubMed)

Headache in Pregnancy: An Approach to Emergency Department Evaluation and Management Headache is a common presenting complaint in the emergency department. The differential diagnosis is broad and includes benign primary causes as well as ominous secondary causes. The diagnosis and management of headache in the pregnant patient presents several challenges. There are important unique considerations regarding the differential diagnosis, imaging options, and medical management. Physiologic changes (...) induced by pregnancy increase the risk of cerebral venous thrombosis, dissection, and pituitary apoplexy. Preeclampsia, a serious condition unique to pregnancy, must also be considered. A high index of suspicion for carbon monoxide toxicity should be maintained. Primary headaches should be a diagnosis of exclusion. When advanced imaging is indicated, magnetic resonance imaging (MRI) should be used, if available, to reduce radiation exposure. Contrast agents should be avoided unless absolutely

Full Text available with Trip Pro

2015 Western Journal of Emergency Medicine

37. Effect of pre-administration with aminophylline on the occurrence of post-dural puncture headache in women undergoing caesarean section by combined spinal-epidural anaesthesia. (PubMed)

Effect of pre-administration with aminophylline on the occurrence of post-dural puncture headache in women undergoing caesarean section by combined spinal-epidural anaesthesia. To investigate the effect of the pre-administration with aminophylline on the occurrence of post-dural puncture headache (PDPH) in women undergoing caesarean section by combined spinal-epidural anaesthesia (CSEA).The study enrolled women undergoing elective caesarean sections with CSEA and randomly allocated them (...) aminophylline administration.A total of 120 patients aged 24-38 years (pregnancy range, 38-42 weeks) were randomly allocated into two groups ( n = 60). The incidence of PDPH in group A was significantly lower than group C (two of 59 [3.4%] versus 10 of 58 [17.2%], respectively). There were no related side-effects within 24 h after aminophylline administration in group A.Intraoperative intravenous infusion of 250 mg aminophylline reduced the incidence of PDPH after caesarean section under CSEA with no side

Full Text available with Trip Pro

2018 The Journal of international medical research

38. Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children

psychotropic medication for mild anxiety and/or mood disturbance for 2 weeks Exclusion Criteria: 1) Children and adolescents with significant chronic medical illness: Central Nervous systen (secondary headache disorder other than mild traumatic brain injury); Cardiac, Pulmonary other than stable asthma, Metabolic, Renal, Hepatic 2) Significant psychiatric disorder, such as major depression, somatization disorder, and psychosis 3) Pregnancy 4) Intellectual delay or cognitive limitations precluding (...) Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2018 Clinical Trials

39. Continuous Positive Airway Pressure as a Potential New Treatment for Cluster Headache

3.1.2. is able to separate cluster headache attacks from other types of headache. agrees to maintain current preventive headache and sleep medication regimens (no change in type, frequency, or dose) during the whole study period. Signed informed consent. Exclusion Criteria: disorders with contraindications for use of continuous positive airway pressure (e.g. unable to remove the ventilation mask due to a movement disorders). Nightly cluster headache attacks Pregnancy or planned pregnancy having had (...) Continuous Positive Airway Pressure as a Potential New Treatment for Cluster Headache Continuous Positive Airway Pressure as a Potential New Treatment for Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2018 Clinical Trials

40. Headaches Through a Woman's Life. (PubMed)

Headaches Through a Woman's Life. Headaches affect women across their life span, with menses, pregnancy, and menopause being times that pose unique challenges in diagnosis and treatment. The correct diagnosis and treatment of headache can prevent unnecessary interventions, the worsening of chronic headache disorders, and complications of secondary headaches.The objective of this article is to educate women's health care providers about the diagnosis, differential diagnosis, and treatment (...) of headache during menses, pregnancy, the puerperium, and menopause to improve the quality of care for women with chronic and acute headache.Current articles were reviewed addressing headache during menses, pregnancy, the postpartum period, and menopause. Articles with the highest level of evidence were compiled in this article to provide a summary of recommendations.Multiple diagnostic and therapeutic options for chronic and acute headache are available for women regardless of their stage in life

2018 Obstetrical & Gynecological Survey

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>